Analysis and Commentary STEVEN GROSSMAN 5/8/21 Analysis and Commentary STEVEN GROSSMAN 5/8/21 FDA Priorities for FY 22 Read More Advocacy at a Glance STEVEN GROSSMAN 4/23/21 Advocacy at a Glance STEVEN GROSSMAN 4/23/21 Alliance Hill Day Meetings on April 28-29, with Alliance member participation urgently requested. More on Acting FDA Commissioner Woodcock’s meeting with the Alliance. Read More Analysis and Commentary STEVEN GROSSMAN 4/16/21 Analysis and Commentary STEVEN GROSSMAN 4/16/21 Highlights from the Past Week Read More Advocacy at a Glance STEVEN GROSSMAN 4/16/21 Advocacy at a Glance STEVEN GROSSMAN 4/16/21 The Alliance is beginning Hill Day meetings. Acting FDA Commissioner Woodcock responded to a wide range of questions during her meeting with the Alliance. Read More Advocacy at a Glance STEVEN GROSSMAN 4/9/21 Advocacy at a Glance STEVEN GROSSMAN 4/9/21 Acting FDA Commissioner Dr. Janet Woodcock will address the Alliance on April 14. A preview of President Biden’s Budget Request will be released on April 9. Read More Advocacy at a Glance STEVEN GROSSMAN 4/3/21 Advocacy at a Glance STEVEN GROSSMAN 4/3/21 Acting FDA Commissioner Dr. Janet Woodcock will address the Alliance on April 14. The President’s FY 22 Budget Preview has not yet been released. Read More Advocacy at a Glance STEVEN GROSSMAN 1/22/21 Advocacy at a Glance STEVEN GROSSMAN 1/22/21 Dr. Woodcock is the new Acting Commissioner. Alliance members and other FDA stakeholders are encouraged to express thanks to Congress for supporting FDA. Read More Analysis and Commentary STEVEN GROSSMAN 9/28/18 Analysis and Commentary STEVEN GROSSMAN 9/28/18 Janet Woodcock on CDER's Needs and Opportunities Read More Advocacy at a Glance STEVEN GROSSMAN 9/28/18 Advocacy at a Glance STEVEN GROSSMAN 9/28/18 FDA Appropriations in Limbo and more Read More Advocacy at a Glance STEVEN GROSSMAN 9/7/18 Advocacy at a Glance STEVEN GROSSMAN 9/7/18 Congress Returns; Appropriations Bills Advance and more Read More Advocacy at a Glance STEVEN GROSSMAN 8/31/18 Advocacy at a Glance STEVEN GROSSMAN 8/31/18 Senate Changes in 302(b) Allocations? Read More Advocacy at a Glance STEVEN GROSSMAN 8/24/18 Advocacy at a Glance STEVEN GROSSMAN 8/24/18 Senate Finishes Consideration of DoD/Labor-HHS Mini-bus Funding Bill and more Read More Advocacy at a Glance STEVEN GROSSMAN 8/17/18 Advocacy at a Glance STEVEN GROSSMAN 8/17/18 Ag/FDA Moves in the Senate Read More Advocacy at a Glance STEVEN GROSSMAN 8/5/18 Advocacy at a Glance STEVEN GROSSMAN 8/5/18 Senate Passes FY 19 Ag/FDA Funding as Part of 4-bill Mini-bus Read More Advocacy at a Glance STEVEN GROSSMAN 7/27/18 Advocacy at a Glance STEVEN GROSSMAN 7/27/18 Senate Starts, Doesn’t Finish, Mini-bus Including Ag/FDA Read More Analysis and Commentary STEVEN GROSSMAN 3/16/18 Analysis and Commentary STEVEN GROSSMAN 3/16/18 Key CDER Priorities Need Funding Too Read More
Analysis and Commentary STEVEN GROSSMAN 5/8/21 Analysis and Commentary STEVEN GROSSMAN 5/8/21 FDA Priorities for FY 22 Read More
Advocacy at a Glance STEVEN GROSSMAN 4/23/21 Advocacy at a Glance STEVEN GROSSMAN 4/23/21 Alliance Hill Day Meetings on April 28-29, with Alliance member participation urgently requested. More on Acting FDA Commissioner Woodcock’s meeting with the Alliance. Read More
Analysis and Commentary STEVEN GROSSMAN 4/16/21 Analysis and Commentary STEVEN GROSSMAN 4/16/21 Highlights from the Past Week Read More
Advocacy at a Glance STEVEN GROSSMAN 4/16/21 Advocacy at a Glance STEVEN GROSSMAN 4/16/21 The Alliance is beginning Hill Day meetings. Acting FDA Commissioner Woodcock responded to a wide range of questions during her meeting with the Alliance. Read More
Advocacy at a Glance STEVEN GROSSMAN 4/9/21 Advocacy at a Glance STEVEN GROSSMAN 4/9/21 Acting FDA Commissioner Dr. Janet Woodcock will address the Alliance on April 14. A preview of President Biden’s Budget Request will be released on April 9. Read More
Advocacy at a Glance STEVEN GROSSMAN 4/3/21 Advocacy at a Glance STEVEN GROSSMAN 4/3/21 Acting FDA Commissioner Dr. Janet Woodcock will address the Alliance on April 14. The President’s FY 22 Budget Preview has not yet been released. Read More
Advocacy at a Glance STEVEN GROSSMAN 1/22/21 Advocacy at a Glance STEVEN GROSSMAN 1/22/21 Dr. Woodcock is the new Acting Commissioner. Alliance members and other FDA stakeholders are encouraged to express thanks to Congress for supporting FDA. Read More
Analysis and Commentary STEVEN GROSSMAN 9/28/18 Analysis and Commentary STEVEN GROSSMAN 9/28/18 Janet Woodcock on CDER's Needs and Opportunities Read More
Advocacy at a Glance STEVEN GROSSMAN 9/28/18 Advocacy at a Glance STEVEN GROSSMAN 9/28/18 FDA Appropriations in Limbo and more Read More
Advocacy at a Glance STEVEN GROSSMAN 9/7/18 Advocacy at a Glance STEVEN GROSSMAN 9/7/18 Congress Returns; Appropriations Bills Advance and more Read More
Advocacy at a Glance STEVEN GROSSMAN 8/31/18 Advocacy at a Glance STEVEN GROSSMAN 8/31/18 Senate Changes in 302(b) Allocations? Read More
Advocacy at a Glance STEVEN GROSSMAN 8/24/18 Advocacy at a Glance STEVEN GROSSMAN 8/24/18 Senate Finishes Consideration of DoD/Labor-HHS Mini-bus Funding Bill and more Read More
Advocacy at a Glance STEVEN GROSSMAN 8/17/18 Advocacy at a Glance STEVEN GROSSMAN 8/17/18 Ag/FDA Moves in the Senate Read More
Advocacy at a Glance STEVEN GROSSMAN 8/5/18 Advocacy at a Glance STEVEN GROSSMAN 8/5/18 Senate Passes FY 19 Ag/FDA Funding as Part of 4-bill Mini-bus Read More
Advocacy at a Glance STEVEN GROSSMAN 7/27/18 Advocacy at a Glance STEVEN GROSSMAN 7/27/18 Senate Starts, Doesn’t Finish, Mini-bus Including Ag/FDA Read More
Analysis and Commentary STEVEN GROSSMAN 3/16/18 Analysis and Commentary STEVEN GROSSMAN 3/16/18 Key CDER Priorities Need Funding Too Read More
